ModerateCaution
Curcumin Phytosome
Curcumin and KPV are both used for inflammation claims and may mask worsening symptoms if serious disease is untreated.
Recommendation: Do not use supplement stacks to self-treat IBD, infection, or severe pain.
KPV
Peptide ·Insufficient evidence ·Reviewed May 2026
KPV is the C-terminal Lys-Pro-Val tripeptide of alpha-MSH studied for anti-inflammatory signaling in gut, skin, and immune models. It is not FDA-approved for human use and has no established clinical dose. Human evidence is very limited, so marketed gut-healing or anti-inflammatory protocols should be treated as experimental.
What it's good for
The bottom line
Evidence rating insufficient. Most-documented uses: anti-inflammatory activity in cell and animal models, studied in colitis models, interest in gut-barrier and skin inflammation. 3 sources indexed (2000–2016), with 3 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
KPV appears to reproduce part of alpha-MSH anti-inflammatory activity, including reduced NF-kappaB signaling and pro-inflammatory cytokine expression in experimental systems. Oral delivery concepts often focus on PepT1 transport in intestinal epithelium, but human formulation, exposure, and outcome data remain inadequate. It should not be used to replace IBD, infection, or dermatologic care.1,2
Class
Alpha-MSH-derived anti-inflammatory tripeptide
Found in food
None as a dietary supplement
Low-status signs
No recognized dietary deficiency state exists for this peptide
Dosing
Dosing & protocol.
Common range
No FDA-approved human dose; research protocols are model-specific
Recommended form
Not recommended outside approved research
Peptides are generally not reliably orally bioavailable unless a specific studied oral formulation is used. Human use of research-grade products is not appropriate.
Forms
Forms & what to buy.
Ranked by evidence and value.
Oral Research Capsule Recommended
Human bioavailability and targeted delivery are not established. Claims often rely on PepT1 biology rather than clinical outcome trials.
Topical Research Formulation
Local exposure may be plausible for skin models. Avoid infected or open wounds unless directed.
Injectable Research Peptide
Systemic use is not FDA-approved. Sterility and dose are uncertain.
Cost
What it actually costs.
Real-world pricing across three quality tiers. Assumes Oral Research Capsule.
BudgetBest value
$60 /mo
$2.00 per dose
Mid
$180 /mo
$6.00 per dose
Premium
$450 /mo
$15.00 per dose
Research-market pricing is not a dosing recommendation; human use is not FDA-approved unless specifically stated. Updated 2026-06-04.
Goals
Goal-based dosing.
Lab work
Markers to track.
What to test, the optimal window inside the conventional range, and how long a response takes.
C-Reactive Protein CRP
No validated KPV response marker; CRP may reflect underlying inflammatory disease.
Optimal
0–1 mg/L
Conventional
0–3 mg/L
Responds in
As clinically indicated
0optimal3
Do not use CRP changes to self-manage inflammatory bowel disease.
ESRFecal calprotectin
Fecal Calprotectin Calprotectin
May track intestinal inflammation in IBD care, not KPV-specific effect.
Optimal
0–50 mcg/g
Conventional
0–50 mcg/g
Responds in
Per gastroenterology plan
0optimal50
Use for diagnosed intestinal inflammatory conditions only.
CRPESRCBC
Why people use it
Symptoms it's matched to.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Abdominal cramping
11% relevance
Colitis model data support inflammatory plausibility, but human symptom use is unproven.2
DigestiveInsufficient evidenceAvoid outside research
Persistent symptoms need medical evaluation.
Skin redness
10% relevance
Alpha-MSH-related anti-inflammatory biology may be relevant to skin inflammation models.1,2
AppearanceInsufficient evidenceTopical research only
Dermatitis and infection require diagnosis.
Inflammatory flares
8% relevance
Mechanistic anti-inflammatory evidence is not enough for clinical disease control.1,2
InflammationInsufficient evidenceAvoid self-treatment
Do not replace prescribed immunotherapy.
Safety
Full safety detail.
Side effects
- Unknown long-term immune effects
- Nausea or GI discomfort
- Headache
- Injection-site reaction if misused
- Product contamination or mislabeling risk
Interactions
Interaction records.
InfoCaution
Probiotics
Probiotics can change gut symptoms while KPV claims target gut inflammation, making response hard to interpret.
Recommendation: Change one intervention at a time in clinician-guided gut protocols.
InfoCaution
Quercetin
Quercetin also has anti-inflammatory claims and can confound symptom tracking.
Recommendation: Use conservative combinations and seek care for persistent inflammatory symptoms.
Sources
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Reviews & position papers
1- 1alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugsNeeds sourceNo linkCatania A et al. · Annals of the New York Academy of Sciences · 2006
KPV described as key alpha-MSH fragment
Mechanistic & preclinical
2- 2Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine modelNeeds sourceNo linkViennois E et al. · Cancer Research · 2016
KPV reduced inflammatory signals in mice
- 3Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytesNeeds sourceNo linkBohm M et al. · Journal of Immunology · 2000
KPV affected inflammatory transcription pathways
Keep exploring
Deep dives & adjacent profiles.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
KPV in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.